Valuation: West Pharmaceutical Services, Inc.

Capitalization 23.03B 19.54B 17.89B 16.87B 31.47B 2,194B 31.72B 212B 82.83B 1,045B 86.39B 84.58B 3,616B P/E ratio 2026 *
38.6x
P/E ratio 2027 * 33.8x
Enterprise value 22.28B 18.91B 17.32B 16.33B 30.46B 2,123B 30.7B 205B 80.16B 1,011B 83.61B 81.85B 3,499B EV / Sales 2026 *
6.69x
EV / Sales 2027 * 6.22x
Free-Float
93.54%
Yield 2026 *
0.28%
Yield 2027 * 0.3%
1 day-0.54%
1 week+7.89%
Current month+8.83%
1 month+24.58%
3 months+31.57%
6 months+16.75%
Current year+17.71%
1 week 300.46
Extreme 300.455
330.88
1 month 254.56
Extreme 254.56
330.88
Current year 223.83
Extreme 223.83
330.88
1 year 202.79
Extreme 202.79
330.88
3 years 187.43
Extreme 187.43
415.73
5 years 187.43
Extreme 187.43
475.35
10 years 70.17
Extreme 70.17
475.35
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Investor Relations Contact 59 11/01/2016
Director TitleAgeSince
Director/Board Member 74 16/10/2007
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Change 5d. change 1-year change 3-years change Capi.($)
-0.54%+7.89%+47.58%-10.06% 23.03B
-2.02%-5.77%-37.50%-25.04% 147B
-1.30%-4.20%-12.59%-15.74% 97.77B
-0.86%-2.14%+53.70%+82.30% 58.67B
-0.09%-14.34%-6.56%+51.73% 50.8B
-3.10%-1.53%-17.83%-42.69% 41.17B
-1.68%-12.14% - - 33.42B
-2.22%-1.56%-30.51%-51.18% 23.39B
-2.33%-4.51%-13.05%-2.56% 20.35B
+0.43%+5.66%-19.10%-32.55% 18.74B
Average -1.40%-2.92%-3.99%-5.09% 51.42B
Weighted average by Cap. -1.54%-4.50%-10.19%-3.35%

Financials

2026 *2027 *
Net sales 3.33B 2.83B 2.59B 2.44B 4.55B 317B 4.59B 30.7B 11.98B 151B 12.5B 12.24B 523B 3.54B 3B 2.75B 2.59B 4.84B 337B 4.87B 32.61B 12.73B 161B 13.28B 13B 556B
Net income 607M 515M 472M 445M 830M 57.84B 836M 5.6B 2.18B 27.55B 2.28B 2.23B 95.33B 690M 585M 536M 505M 942M 65.69B 950M 6.35B 2.48B 31.29B 2.59B 2.53B 108B
Net Debt -741M -629M -576M -543M -1.01B -70.64B -1.02B -6.83B -2.67B -33.64B -2.78B -2.72B -116B -1.03B -871M -798M -752M -1.4B -97.79B -1.41B -9.46B -3.69B -46.57B -3.85B -3.77B -161B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change Volume
11/05/26 323.87 $ -0.63% 334,671
08/05/26 325.92 $ +1.21% 1,033,396
07/05/26 322.01 $ +3.03% 1,610,527
06/05/26 312.55 $ +0.83% 789,200
05/05/26 309.97 $ +3.26% 896,962
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
325.92USD
Average target price
349.85USD
Spread / Average Target
+7.34%

Quarterly revenue - Rate of surprise